NEO
NEOGENOMICS INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$19.91
+0.10%Forward multiples
Based on analyst estimates
- P/E forward
- 73.27x
- P/E 2026E
- 107.55x
- P/E 2027E
- 58.11x
- P/E 2028E
- 41.96x
- P/S forward
- 3.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.26x
- Price / sales
- 3.34x
- Price / cash flow
- 116.01x
Enterprise value
- Enterprise value
- $2.9B
- EV / sales
- 3.73x
- EV / EBITDA
- 222.01x
- EV / EBIT
- -43.24x
- Market cap
- $2.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026